Results 261 to 270 of about 1,506,332 (411)

Downregulation of O‐GlcNAcylation enhances etoposide‐induced p53‐mediated apoptosis in HepG2 human liver cancer cells

FEBS Open Bio, EarlyView.
Etoposide, a topoisomerase II inhibitor, reduces O‐GlcNAcylation in HepG2 liver cancer cells. Further inhibition of O‐GlcNAc transferase by OSMI‐1 enhanced etoposide‐induced apoptosis, lowering the IC50 for viability and increasing the EC50 for cytotoxicity.
Jaehoon Lee, Gi‐Bang Koo, Jihye Park, Byung‐Cheol Han, Mijin Kwon, Seung‐Ho Lee   +5 more
wiley   +1 more source

Thyroid Nodules with Nuclear Atypia of Undetermined Significance (AUS-Nuclear) Hold a Two-Times-Higher Risk of Malignancy than AUS-Other Nodules Regardless of EU-TIRADS Class of the Nodule or Borderline Tumor Interpretation. [PDF]

Cancers (Basel)
Słowińska-Klencka D, Popowicz B, Duda-Szymańska J, Klencki M.   +3 more
europepmc   +1 more source

Calcified Atherosclerosis and Cancer of Low Malignancy

, 1963
A. Elkeles
openalex   +1 more source

Advanced glycation end products promote the release of endothelial cell‐derived mitocytosis

FEBS Open Bio, EarlyView.
Under diabetic conditions, AGEs induce mitochondrial damage in HUVECs, activating migrasome‐mediated mitocytosis. Migrasomes encapsulate damaged mitochondria and are released into the extracellular space, facilitating intercellular mitochondrial transfer.
Rong Liu, Yuhao Zhang, Tiantian Ge, Hao Wu, Yongbin Ma, Honghua Ye, Fei Guo   +6 more
wiley   +1 more source

HT1080 Human Fibrosarcoma Cells Selected for Super-eribulin Resistance <i>In Vitro</i> Become More Malignant and Are Arrested Synergistically by Methionine Restriction in Combination With Eribulin in Nude Mice. [PDF]

In Vivo
Morinaga S, Mizuta K, Kang BM, Han Q, Bouvet M, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Higuchi T, Tsuchiya H, Demura S, Hoffman RM.   +13 more
europepmc   +1 more source

Modern Aspects of Medical Treatment of Malignancy: The Use and Abuse of Cytotoxic Agents [PDF]

, 1966
G Westbury
openalex   +1 more source

Long non‐coding RNAs as therapeutic targets in head and neck squamous cell carcinoma and clinical application

FEBS Open Bio, EarlyView.
Long non‐coding RNAs (lncRNAs) occupy an abundant fraction of the eukaryotic transcriptome and an emerging area in cancer research. Regulation by lncRNAs is based on their subcellular localization in HNSCC. This cartoon shows the various functions of lncRNAs in HNSCC discussed in this review.
Ellen T. Tran, Ruchi A. Patel, Amogh Chariyamane, Ratna B. Ray   +3 more
wiley   +1 more source

Comparing the clinical characteristics and risk factors of prognosis in pediatric ARDS with and without malignancies: a retrospective cohort study. [PDF]

BMC Pulm Med
Xiong X, Cui Y, Wang C, Zhou Y, Ma X, Li P, Zhang Y.   +6 more
europepmc   +1 more source

Respiratory Manifestations and Chest X-Ray Findings in the Metastatic Lung Malignancy [PDF]

, 1968
Ok Bum Lee, Joo Kyong Lee, Tae Kyoung Kim, Nak Hun Sung   +3 more
openalex   +1 more source

The Clinical Relevance of Distinguishing Between Simple and Complex Adnexal Cystic Structures by Ultrasound in Peri- and Postmenopause. [PDF]

Cancers (Basel)
Erdodi B, Szollosi GJ, Toth Z, Krasznai ZT, Jakab A.   +4 more
europepmc   +1 more source